Trials / Terminated
TerminatedNCT05250583
Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis
Use of a Double Amniotic Membrane Inserted in a Ring of Umbilical Vessels with Wharton's Jelly, Tissues Treated by the AMTRIX Process, in the Treatment of Keratitis Resisting Healing Medical Treatment
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- TBF Genie Tissulaire · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this open, mono center trial is to assess the impact of the use of an amniotic membrane on the healing of a keratitis resistant to medical treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | LV-Visio-AMTRIX | Chemically-treated, viro-inactivated, freeze-dried and irradiated allograft placed by the investigator during patients' hospital visit |
Timeline
- Start date
- 2020-06-29
- Primary completion
- 2021-01-07
- Completion
- 2021-01-07
- First posted
- 2022-02-22
- Last updated
- 2024-11-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05250583. Inclusion in this directory is not an endorsement.